Layer-Specific Changes in the Prefrontal Glia/Neuron Ratio Characterizes Patches of Gene Expression Disorganization in Children with Autism.
Livia Nascimento Rabelo, José Pablo Gonçalves Queiroz, Carla Cristina Miranda Castro and 6 others
PMID 35704132WHAT IT FOUND
Postmortem analysis of 11 children with autism found the dorsolateral prefrontal cortex had a lower ratio of glial cells to neurons than in non-autistic controls.
This cellular imbalance was most pronounced in superficial layers and in patches where gene expression was disrupted.
Key findings
01The average glia/neuron ratio in the dorsolateral prefrontal cortex was significantly lower in the autism group compared to the non-autism group.
02Within the autism group, the glia/neuron ratio was significantly lower in cortical patches than in non-patch regions, specifically in layers II-III.
03The study found no significant difference in the glia/neuron ratio between patch and non-patch regions in the deeper layers V-VI.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study used postmortem tissue, so it cannot determine if these cellular changes cause autism symptoms or are a consequence of other factors. The sample size was small (11 cases per group). Researchers could not measure absolute cell numbers or sizes because they worked from digital images rather than direct microscopy, relying on density ratios instead. The donors had varying ages and postmortem intervals, though statistical analysis found no significant effect of these variables on the results.
Declared interests
The authors declared no conflicts of interest. The study used data from the Allen Human Brain Atlas, supported by the National Institute of Child Health and Human Development and other brain tissue banks.
The easy way to misread this
Do not interpret this as evidence that altering glial or neuronal density can treat autism. This is a descriptive neuropathological finding in postmortem tissue that suggests a developmental origin, not a testable intervention or diagnostic tool for living patients.